Browse result page of THPdb

The total number entries retrieved from this search are 46

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1205	ThPPIDTh1027	NameInsulin Regular	Peptide SequenceA-chain:GIVEQCCTSIC< Full view	Length51	Functional ClassificationIa	DiseaseGenetic/Hormonal	BrandHumulin R	CompanyEli Lilly and Company	Physical AppearanceSterile, clear, aqueous, and colorless solution	Route of AdministartionSubcutaneous injection in the abdominal wall, the thigh, the gluteal region or in the upper arm and Intravenousadministration of Humulin R (insulin (human recombinant)) U-100 is possible under medical supervision.	CategoryAntidiabetic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1206	ThPPIDTh1027	NameInsulin Regular	Peptide SequenceA-chain:GIVEQCCTSIC< Full view	Length51	Functional ClassificationIa	DiseaseGenetic/Hormonal	BrandNovolin R	CompanyNovo Nordisk	Physical AppearanceSterile, clear, aqueous, and colorless solution	Route of AdministartionSubcutaneous and Intravenous infusion	CategoryAntidiabetic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1252	ThPPIDTh1035	NameGlucagon recombinant	Peptide SequenceHSQGTFTSDYSKYLDSRRAQ Full view	Length29	Functional ClassificationIV	DiseaseHormonal/Metabolic/genetic	BrandGlucaGen	CompanyNovo Nordisk	Physical AppearanceSterile, lyophilized white powder	Route of AdministartionSubcutaneous, Intramuscular, or Intravenous infusion	CategoryHypoglycemic Agents	TargetGlucagon receptor,Glucagon-like peptide 2 receptor,Glucagon-like peptide 1 receptor
ID1253	ThPPIDTh1035	NameGlucagon recombinant	Peptide SequenceHSQGTFTSDYSKYLDSRRAQ Full view	Length29	Functional ClassificationIV	DiseaseHormonal/Metabolic/genetic	BrandGlucagon	CompanyEli Lilly	Physical AppearancePowder	Route of AdministartionSubcutaneously or Intramuscularly Injection	CategoryHypoglycemic Agents	TargetGlucagon receptor,Glucagon-like peptide 2 receptor,Glucagon-like peptide 1 receptor
ID1275	ThPPIDTh1040	NameInsulin Lispro	Peptide SequenceA chain:GIVEQCCTSICS Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandHumalog	CompanyEli Lilly	Physical AppearanceSterile, aqueous, clear, and colorless solution	Route of AdministartionSubcutaneous and Intravenous infusion	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1276	ThPPIDTh1040	NameInsulin Lispro	Peptide SequenceA chain:GIVEQCCTSICS Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandHumalog KwikPen	CompanyEli Lilly	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1277	ThPPIDTh1040	NameInsulin Lispro	Peptide SequenceA chain:GIVEQCCTSICS Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandHumalog Pen	CompanyEli Lilly	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1283	ThPPIDTh1041	NameInsulin Glargine	Peptide SequenceA-chain:GIVEQCCTSICS Full view	Length53	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandLantus	CompanySanofi-Aventis	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1284	ThPPIDTh1041	NameInsulin Glargine	Peptide SequenceA-chain:GIVEQCCTSICS Full view	Length53	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandLantus OptiSet	CompanyN.A.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1285	ThPPIDTh1041	NameInsulin Glargine	Peptide SequenceA-chain:GIVEQCCTSICS Full view	Length53	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandLantus SoloStar	CompanyN.A.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1305	ThPPIDTh1043	NameRasburicase	Peptide SequenceSAVKAARYGKDNVRVYKVHK Full view	Length255	Functional ClassificationIc	DiseaseMetabolic/Genetic	BrandElitek	CompanySanofi-Synthelabo Inc	Physical AppearanceSterile, white to off-white, lyophilized powder	Route of AdministartionIntravenous administration	CategoryAntihyperuricemic Agents, Gout suppressants	TargetUric acid
ID1306	ThPPIDTh1043	NameRasburicase	Peptide SequenceSAVKAARYGKDNVRVYKVHK Full view	Length255	Functional ClassificationIc	DiseaseMetabolic/Genetic	BrandFasturtec	CompanyN.A.	Physical AppearancePowder and solvent that are made upto make solution.	Route of AdministartionIntravenous administartion	CategoryAntihyperuricemic Agents, Gout suppressants	TargetUric acid
ID1327	ThPPIDTh1046	NameAbciximab	Peptide SequenceH ReoPro-like antibo Full view	Length218	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Haemetological	BrandReoPro	CompanyEli Lilly and Company	Physical AppearanceClear, colorless, sterile, non-pyrogenic solution	Route of AdministartionIntravenous administartion	CategoryPlatelet Aggregation Inhibitors, Anticoagulants	TargetIntegrin beta-3,Integrin alpha-IIb,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immuno
ID1361	ThPPIDTh1051	NameHuman Serum Albumin	Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view	Length609	Functional ClassificationIa	DiseaseHematological/Metabolic/genetic	BrandAlbuminar	CompanyCSL Behring	Physical AppearanceSterile aqueous solution of albumin obtained from large pools of adult human venous plasma by low temperature controlled fractionation according to the Cohn process.	Route of AdministartionAlbumin (Human) 25%, Albuminar-25 (albumin human) , is to be administered by the Intravenous route.	CategorySerum substitutes	TargetN.A.
ID1362	ThPPIDTh1051	NameHuman Serum Albumin	Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view	Length609	Functional ClassificationIa	DiseaseHematological/Metabolic/genetic	BrandAlbutein	CompanyGRIFOLS	Physical AppearanceSterile, aqueous solution for single dose intravenous administration containing 20% human albumin (weight/volume).	Route of AdministartionAlbutein 20% is to be administered by the Intravenous route.	CategorySerum substitutes	TargetN.A.
ID1422	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandPancrecarb	CompanyDigestive care US, Inc.	Physical AppearanceDelayed-Release Capsules, Buffered and Enteric-Coated Microspheres.	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1423	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandViokace	CompanyAptalis Pharma US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble in alcohol and converted to tablet form	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1424	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandULTRESA	CompanyAptalis Pharma US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble or insoluble in alcohol and ether and converted to Delayed-Release Capsules	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1425	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandPERTZYE	CompanyDigestive care US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble or insoluble in alcohol and ether PERTZYE delayed-release capsule	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1426	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandULTRASE	CompanyAxcan Pharma	Physical AppearanceCapsules Enteric-Coated Microspheres	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1427	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandZENPEP	CompanyAptalis Pharma US, Inc.	Physical AppearanceDelayed-Release Capsules	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1445	ThPPIDTh1079	NameSerum Albumin	Peptide SequenceDAHKSEVAHRFKDLGEENFK Full view	Length585	Functional ClassificationIV	DiseaseMetabolic/genetic	BrandAlbunex	CompanyMallinckrodt; Tyco Healthcare	Physical AppearanceN.A.	Route of AdministartionIntravenous infusion	CategorySerum substitutes	TargetN.A.
ID1446	ThPPIDTh1079	NameSerum Albumin	Peptide SequenceDAHKSEVAHRFKDLGEENFK Full view	Length585	Functional ClassificationIV	DiseaseMetabolic/genetic	BrandOptison	CompanyGE Healthcare	Physical AppearanceN.A.	Route of AdministartionIntravenous infusion	CategorySerum substitutes	TargetN.A.
ID1453	ThPPIDTh1083	NameCoagulation Factor Ix	Peptide SequenceYNSGKLEEFVQGNLERECME Full view	Length415	Functional ClassificationIa	DiseaseHematological/Metabolic/genetic	BrandAlprolix	CompanyBiogen Idec Inc., and Genentech USA, Inc	Physical AppearanceSterile, non-pyrogenic, preservative-free, white to off-white, lyophilized powder to cake for reconstitution with the provided diluent	Route of AdministartionIntravenous infusion	CategoryCoagulants and Thrombotic Agents	TargetN.A.
ID1549	ThPPIDTh1118	NameSulodexide	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIIc	DiseaseHormonal/genetic/Hematological/N.A.	BrandSULODEXIDE	CompanySyntex S.A	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntithrombins and Fibrinolytic Agents and Hypoglycemic Agents and Anticoagulants and Hypolipidemic Agents	TargetHeparin cofactor 2,Antithrombin-III
ID1641	ThPPIDTh1146	NameLucinactant	Peptide SequenceKLLLLKLLLLKLLLLKLLLL Full view	Length21	Functional ClassificationIb	DiseaseGenetic	BrandSurfaxin	CompanyDiscovery Laboratories, Inc.	Physical AppearanceSuspension	Route of AdministartionIntratracheal administration	CategoryPulmonary surfactants	TargetN.A.
ID1644	ThPPIDTh1147	NameNatalizumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Immunological	BrandTysabri	CompanyBiogen Idec Inc.	Physical AppearanceSterile, colorless, and clear to slightly opalescent concentrate	Route of AdministartionIntravenous infusion	CategoryImmunosuppressive agents	TargetN.A.
ID1694	ThPPIDTh1166	NameAsfotase Alfa	Peptide SequenceLVPEKEKDPKYWRDQAQETL Full view	Length726	Functional ClassificationIa	DiseaseGenetic Disorders	BrandStrensiq	CompanyAlexion Pharma Ghbh	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryEnzymes Alimentary Tract and Metabolism	TargetSphingosine 1-phosphate receptor 1; Pyrophosphate
ID1695	ThPPIDTh1166	NameAsfotase Alfa	Peptide SequenceLVPEKEKDPKYWRDQAQETL Full view	Length726	Functional ClassificationIa	DiseaseGenetic Disorders	BrandStrensiq	CompanyAlexion Pharmaceuticals Inc.	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryEnzymes Alimentary Tract and Metabolism	TargetSphingosine 1-phosphate receptor 1; Pyrophosphate
ID1708	ThPPIDTh1170	NameBlinatumomab	Peptide SequenceDIQLTQSPASLAVSLGQRAT Full view	Length504	Functional ClassificationIIIc	DiseaseCancer/Genetic	BrandBlincyto	CompanyAMGEN	Physical AppearanceLyophilized Powder for intravenous administration	Route of AdministartionIntravenous	CategoryAntineoplastic Agents, Immunosuppressive Agents, Monoclonal antibodies, Antineoplastic and Immunomodulating Agents	TargetB-lymphocyte antigen CD19; T-cell surface glycoprotein CD3 delta chain
ID1715	ThPPIDTh1171	NameC1 Esterase Inhibitor (Human)	Peptide SequenceNA Full view	Length0	Functional ClassificationIa	DiseaseGenetic Disorders	BrandBerinert 1500	CompanyCsl Behring Canada Inc	Physical Appearancekit; Powder for Solution	Route of AdministartionIntravenous	CategoryNA	TargetPlasma protease C1 inhibitor
ID1717	ThPPIDTh1171	NameC1 Esterase Inhibitor (Human)	Peptide SequenceNA Full view	Length0	Functional ClassificationIa	DiseaseGenetic Disorders	BrandCinryze	CompanyViropharma Biologics Inc	Physical AppearancePowder for Solution	Route of AdministartionIntravenous	CategoryNA	TargetPlasma protease C1 inhibitor
ID1722	ThPPIDTh1173	NameConestat alfa	Peptide SequenceNA Full view	Length0	Functional ClassificationIa	DiseaseGenetic Disorders	BrandRuconest	CompanyPharming; Santarus, Inc.	Physical AppearancePowder for Solution	Route of AdministartionIntravenous	CategoryNA	TargetNA
ID1741	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandNA	CompanyNA	Physical AppearanceInjection, Solution; Injection	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 9
ID1742	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandRepatha	CompanyAmgen Inc	Physical AppearanceInjection, Solution	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 10
ID1743	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandRepatha	CompanyAmgen Canada Inc	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 11
ID1744	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandRepatha	CompanyAmgen Inc	Physical AppearanceInjection, Solution	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 12
ID1745	ThPPIDTh1180	NameFibrinogen Concentrate (Human)	Peptide SequenceNA Full view	Length0	Functional ClassificationIa	DiseaseGenetic/Hematological	BrandRiastap	CompanyCsl Behring Gmb H	Physical AppearanceInjection, Powder, Lyophilized, for Solution	Route of AdministartionIntravenous	CategoryNA	TargetNA
ID1746	ThPPIDTh1180	NameFibrinogen Concentrate (Human)	Peptide SequenceNA Full view	Length0	Functional ClassificationIa	DiseaseGenetic/Hematological	BrandArtiss Frozen	CompanyBaxter Healthcare Corporation	Physical AppearanceNA	Route of AdministartionNA	CategoryNA	TargetNA
ID1747	ThPPIDTh1180	NameFibrinogen Concentrate (Human)	Peptide SequenceNA Full view	Length0	Functional ClassificationIa	DiseaseGenetic/Hematological	BrandEvicel Fibrin Sealant (human)	CompanyEthicon Inc	Physical AppearanceNA	Route of AdministartionNA	CategoryNA	TargetNA
ID1748	ThPPIDTh1180	NameFibrinogen Concentrate (Human)	Peptide SequenceNA Full view	Length0	Functional ClassificationIa	DiseaseGenetic/Hematological	BrandRaplixa	CompanyPro Fibrix Bv	Physical AppearanceNA	Route of AdministartionNA	CategoryNA	TargetNA
ID1749	ThPPIDTh1180	NameFibrinogen Concentrate (Human)	Peptide SequenceNA Full view	Length0	Functional ClassificationIa	DiseaseGenetic/Hematological	BrandTachosil	CompanyBaxter Healthcare Corporation	Physical AppearanceNA	Route of AdministartionNA	CategoryNA	TargetNA
ID1750	ThPPIDTh1180	NameFibrinogen Concentrate (Human)	Peptide SequenceNA Full view	Length0	Functional ClassificationIa	DiseaseGenetic/Hematological	BrandTisseel	CompanyBaxter Healthcare Corporation	Physical AppearanceNA	Route of AdministartionNA	CategoryNA	TargetNA
ID1751	ThPPIDTh1180	NameFibrinogen Concentrate (Human)	Peptide SequenceNA Full view	Length0	Functional ClassificationIa	DiseaseGenetic/Hematological	BrandTisseel Frozen	CompanyBaxter Healthcare Corporation	Physical AppearanceNA	Route of AdministartionNA	CategoryNA	TargetNA
ID1803	ThPPIDTh1197	NameSebelipase alfa	Peptide SequenceSGGKLTAVDPETNMNVSEII Full view	Length378	Functional ClassificationIa	DiseaseGenetic Disorders	BrandKanuma	CompanyAlexion Pharmaceuticals, Inc.	Physical AppearanceAqueous Solution	Route of AdministartionIntravenous infusion	CategoryEnzymes	TargetNA
ID1804	ThPPIDTh1198	NameSacrosidase	Peptide SequenceNA Full view	Length0	Functional ClassificationIa	DiseaseGenetic Disorders	BrandSucraid	CompanyQOL Medical, LLC	Physical AppearanceSolution	Route of AdministartionOral	CategoryEnzymes	TargetNA